HK1159250A1 - Improved method of rna display rna - Google Patents

Improved method of rna display rna

Info

Publication number
HK1159250A1
HK1159250A1 HK11113810.8A HK11113810A HK1159250A1 HK 1159250 A1 HK1159250 A1 HK 1159250A1 HK 11113810 A HK11113810 A HK 11113810A HK 1159250 A1 HK1159250 A1 HK 1159250A1
Authority
HK
Hong Kong
Prior art keywords
rna
improved method
display
rna display
improved
Prior art date
Application number
HK11113810.8A
Other languages
English (en)
Inventor
Chung-Ming Hsieh
Yuliya A Kutskova
John E Memmott
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HK1159250A1 publication Critical patent/HK1159250A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK11113810.8A 2008-09-30 2011-12-21 Improved method of rna display rna HK1159250A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10147108P 2008-09-30 2008-09-30
PCT/US2009/059057 WO2010039850A1 (en) 2008-09-30 2009-09-30 Improved method of rna display

Publications (1)

Publication Number Publication Date
HK1159250A1 true HK1159250A1 (en) 2012-07-27

Family

ID=42073857

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113810.8A HK1159250A1 (en) 2008-09-30 2011-12-21 Improved method of rna display rna

Country Status (17)

Country Link
US (1) US8916504B2 (xx)
EP (1) EP2342562B1 (xx)
JP (1) JP5968624B2 (xx)
KR (1) KR20110076906A (xx)
CN (1) CN102227638B (xx)
AU (1) AU2009298499A1 (xx)
BR (1) BRPI0919426A2 (xx)
CA (1) CA2737035A1 (xx)
ES (1) ES2434850T3 (xx)
HK (1) HK1159250A1 (xx)
IL (1) IL211551A (xx)
MX (1) MX2011003381A (xx)
NZ (1) NZ591544A (xx)
RU (1) RU2011117210A (xx)
TW (1) TW201024731A (xx)
WO (1) WO2010039850A1 (xx)
ZA (1) ZA201102120B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231736A1 (en) 2000-12-22 2002-07-08 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Use of repulsive guidance molecule (rgm) and its modulators
WO2007039256A2 (de) * 2005-09-30 2007-04-12 Abbott Gmbh & Co. Kg Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
EP2033971A1 (de) * 2007-09-06 2009-03-11 Abbott GmbH & Co. KG Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
US8962803B2 (en) * 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
CA2722466A1 (en) * 2008-04-29 2009-11-05 Tariq Ghayur Dual variable domain immunoglobulins and uses thereof
CA2725666A1 (en) * 2008-06-03 2009-12-10 Abbott Laboratories Dual variable domain immunoglobulins and uses thereof
AU2009256250B2 (en) * 2008-06-03 2013-05-30 Abbvie Inc. Dual variable domain immunoglobulins and uses thereof
NZ590074A (en) * 2008-07-08 2012-12-21 Abbott Lab Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
AU2010242840B2 (en) * 2009-05-01 2014-04-17 Abbvie Inc. Dual variable domain immunoglobulins and uses thereof
UY32808A (es) * 2009-07-29 2011-02-28 Abbott Lab Inmunoglobulinas como dominio variable dual y usos de las mismas
KR20140015139A (ko) * 2009-10-15 2014-02-06 애브비 인코포레이티드 이원 가변 도메인 면역글로불린 및 이의 용도
UY32979A (es) 2009-10-28 2011-02-28 Abbott Lab Inmunoglobulinas con dominio variable dual y usos de las mismas
CN102656190A (zh) * 2009-12-08 2012-09-05 雅培股份有限两合公司 用于在视网膜神经纤维层变性治疗中使用的针对rgm a蛋白质的单克隆抗体
CA2807014A1 (en) 2010-08-03 2012-02-09 Abbvie Inc. Dual variable domain immunoglobulins and uses thereof
TW201211252A (en) * 2010-08-26 2012-03-16 Abbott Lab Dual variable domain immunoglobulins and uses thereof
EP2686349B1 (en) 2011-03-15 2020-12-09 X-Body, Inc. Antibody screening methods
EP3318880B1 (en) 2011-05-17 2020-12-16 Bristol-Myers Squibb Company Improved methods for the selection of binding proteins
UY34558A (es) 2011-12-30 2013-07-31 Abbvie Inc Proteínas de unión específicas duales dirigidas contra il-13 y/o il-17
IL305223A (en) 2012-01-27 2023-10-01 Abbvie Inc The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
AU2013337775B2 (en) 2012-11-01 2017-03-30 Abbvie Inc. Anti-VEGF/DLL4 dual variable domain immunoglobulins and uses thereof
WO2014142020A1 (ja) * 2013-03-13 2014-09-18 国立大学法人東京大学 核酸リンカー
CN105324396A (zh) 2013-03-15 2016-02-10 艾伯维公司 针对IL-1β和/或IL-17的双重特异性结合蛋白
ES2791068T3 (es) 2013-06-28 2020-10-30 X Body Inc Descubrimiento de antígenos objetivo, cribados fenotípicos y uso de los mismos para la identificación de epítopos objetivo específicos de células objetivo
EP3102245B1 (en) 2014-02-05 2021-09-08 Molecular Templates, Inc. Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity
US10093733B2 (en) 2014-12-11 2018-10-09 Abbvie Inc. LRP-8 binding dual variable domain immunoglobulin proteins
CN107614014B (zh) * 2015-05-28 2022-07-12 生物辐射实验室股份有限公司 亲和配体及其相关方法
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
AU2017271601A1 (en) 2016-05-27 2018-12-13 Abbvie Biotherapeutics Inc. Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
KR20230174295A (ko) * 2017-11-20 2023-12-27 난트바이오 인코포레이티드 mRNA 디스플레이 항체 라이브러리 및 방법
CN113710801A (zh) * 2019-02-22 2021-11-26 爱普思隆分子进化工程株式会社 一种使用cDNA展示的新型免疫PCR方法
WO2022087804A1 (zh) * 2020-10-27 2022-05-05 北京寻因生物科技有限公司 一种嘌呤霉素连接子及其在体外核酸展示肽合成中的应用
WO2022104001A1 (en) 2020-11-13 2022-05-19 Bristol-Myers Squibb Company Expanded protein libraries and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310652A (en) * 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US5401650A (en) * 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
US5922545A (en) * 1993-10-29 1999-07-13 Affymax Technologies N.V. In vitro peptide and antibody display libraries
US8207093B2 (en) * 1997-01-21 2012-06-26 The General Hospital Corporation Selection of proteins using RNA-protein fusions
PT985032E (pt) * 1997-05-28 2004-02-27 Discerna Ltd Complexos ribossomicos como particulas de seleccao para apresentacao in vitro e evolucao de proteinas
US6927025B1 (en) * 1997-09-03 2005-08-09 Biovation Limited Methods for protein screening
US6914128B1 (en) * 1999-03-25 2005-07-05 Abbott Gmbh & Co. Kg Human antibodies that bind human IL-12 and methods for producing
CA2374085C (en) * 1999-05-14 2015-12-29 Genentech, Inc. Tumour treatment with anti-erbb2 antibodies
US6830902B1 (en) * 1999-07-02 2004-12-14 Invitrogen Corporation Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
DK1196637T3 (da) * 1999-07-27 2007-07-30 Adnexus Therapeutics Inc Peptidacceptor-ligeringsmetoder
US7264932B2 (en) * 1999-09-24 2007-09-04 Applera Corporation Nuclease inhibitor cocktail
ES2253358T3 (es) * 2000-03-31 2006-06-01 Cambridge Antibody Technology Limited Mejoras en la visualizacion del ribosoma.
JP4963142B2 (ja) * 2000-12-14 2012-06-27 学校法人慶應義塾 遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
ES2615362T3 (es) * 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
CA2484930A1 (en) * 2002-05-06 2003-11-13 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
CA2504481A1 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
AU2004296376B2 (en) * 2003-12-05 2010-03-04 Bristol-Myers Squibb Company Inhibitors of type 2 vascular endothelial growth factor receptors
US8822191B2 (en) * 2004-02-04 2014-09-02 Novo Nordisk A/S Methods of refolding mammalian glycosyltransferases
US7662926B2 (en) * 2004-09-02 2010-02-16 Genentech, Inc. Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
JP2006141348A (ja) * 2004-11-24 2006-06-08 Zoegene Corp 標的物質と相互作用するドメインポリペプチドの選抜取得方法および構造モチーフ配列の同定方法並びに分子設計方法
GB0500099D0 (en) * 2005-01-05 2005-02-09 Cambridge Antibody Tech Methods and means relating to protein variants
US20070218478A1 (en) * 2005-12-16 2007-09-20 Affymetrix, Inc. Methods for fragmentation and analysis of nucleic acid
JP2007191477A (ja) * 2005-12-22 2007-08-02 Cellfree Sciences Co Ltd 風疹ウイルスタンパク質の製造方法
AR059900A1 (es) * 2006-03-17 2008-05-07 Genentech Inc Anticuerpos anti-tat226 e inmunoconjugados
WO2007109254A2 (en) * 2006-03-17 2007-09-27 Biogen Idec Ma Inc. Stabilized polypeptide compositions
US7749957B2 (en) * 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
WO2007136835A2 (en) * 2006-05-19 2007-11-29 Codon Devices, Inc Methods and cells for creating functional diversity and uses thereof

Also Published As

Publication number Publication date
EP2342562A1 (en) 2011-07-13
ES2434850T3 (es) 2013-12-17
ZA201102120B (en) 2011-12-28
TW201024731A (en) 2010-07-01
AU2009298499A1 (en) 2010-04-08
CA2737035A1 (en) 2010-04-08
CN102227638A (zh) 2011-10-26
JP2012504415A (ja) 2012-02-23
MX2011003381A (es) 2011-04-21
EP2342562B1 (en) 2013-09-18
IL211551A (en) 2014-06-30
KR20110076906A (ko) 2011-07-06
JP5968624B2 (ja) 2016-08-10
CN102227638B (zh) 2015-05-20
EP2342562A4 (en) 2012-03-21
BRPI0919426A2 (pt) 2015-12-15
NZ591544A (en) 2013-01-25
WO2010039850A1 (en) 2010-04-08
US20100105569A1 (en) 2010-04-29
IL211551A0 (en) 2011-05-31
US8916504B2 (en) 2014-12-23
RU2011117210A (ru) 2012-11-10

Similar Documents

Publication Publication Date Title
HK1159250A1 (en) Improved method of rna display rna
EG25742A (en) Photobioreactor
EP2354833A4 (en) METHOD FOR MANUFACTURING DISPLAY PANEL
GB0810051D0 (en) Method of diagnosis
EP2324131A4 (en) PROCESS FOR ISOLATING SMALL RNA
PL2376507T3 (pl) Sposób otrzymywania hydroksymetylofosfonianów
EP2172547A4 (en) PROCESS FOR EXPRESSING A SPECIFIC GENE
EP2389454A4 (en) METHOD FOR ENRICHING RNA SELECTED MOLECULES
HK1162196A1 (en) Method for quantification of small rna species rna
GB0711697D0 (en) Method of manufacture
IL207979A0 (en) Method of scanning
GB2465869B (en) Electrophoresis display
ZA201005430B (en) Selection of targeted advertisements
EP2351818A4 (en) METHOD FOR STARTING A RECTIFICATION COLUMN
EP2309852A4 (en) NOVEL PROCEDURE
EP2430180A4 (en) gene synthesis
EP2284144A4 (en) POLYFLUORO-1-ALKANE AND METHOD FOR PRODUCING THE SAME
EP2333109A4 (en) RNA DETECTION COMPOSITION
GB0817384D0 (en) Method of providing location data
EP2397543A4 (en) METHOD FOR PRODUCING A DNA TAG
EP2362910A4 (en) METHOD FOR DNA CLONING
GB2459738B (en) Method of purification
GB0905458D0 (en) Method of altering nucleic acids
PL385356A1 (pl) Sposób wytwarzania tadalafilu
GB0813123D0 (en) Method of searching

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170930